Alpha Bank S.A. (ALPHA)
Athens Exchange · Greece · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 4.098 |
|---|---|
| 52-week range | 2.950 – 4.940 |
| Return, 1 month / 3 months | −9.0% / +4.6% |
| Return, 1 year / 3 years | +17.4% / +240.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 38 |
| Volatility (1 year) | 41.5% |
| Worst drawdown (1 year) | -33.4% |
| Average daily value traded | 44.06M EUR |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alpha Bank is a Greek commercial bank based in Athens. It serves individuals, households, small businesses and larger corporate clients through a network of branches and digital channels. Its services include deposit accounts, consumer and mortgage lending, business and corporate finance, cards, payments and wealth management. The bank also runs investment and insurance-related activities and has operations in southeastern Europe, giving it a presence beyond its home market in Greece.
On this site Alpha Bank S.A. appears as a stock on the Athens Exchange (Greece), code ALPHA, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alpha Bank S.A. (ALPHA) trades on the Athens Exchange in Greece. It last closed at EUR 4.098 on 23 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 47 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.4% and over the last three months it rose 4.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Athens Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.8% | ||
| From 52-week high | -16.5% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.6% | ||
| 6-month return | 14.2% | ||
| 12-month return, skipping the last month | 29.0% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.4% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 44.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.0% |
|---|---|
| 1 month | −9.0% |
| 3 months | +4.6% |
| 6 months | +14.2% |
| 1 year | +17.4% |
| 3 years | +240.7% |
| 5 years | +283.7% |
Signals
| 50-day / 200-day average | 4.551 / 3.986 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.155 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jul 2026 | EUR 0.0656 |
| 1 Dec 2025 | EUR 0.0485 |
| 23 May 2025 | EUR 0.0265 |
| 26 Jul 2024 | EUR 0.0227 |
| 25 Oct 2022 | EUR 0.0070 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.